First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NOX-H94
Clinical trial NCT01372137 · COMPLETED
Trial details
- NCT number
- NCT01372137
- Sponsor
- TME Pharma AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-03-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.